Skip to main content
Clinical Trials/NCT02713308
NCT02713308UnknownNot Applicable

Impact of MultiPoint Pacing Technology in CRT Patients With Reduced RV-to-LV Delay

Monaldi Hospital2 sites in 1 country248 target enrollmentStarted: January 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
248
Locations
2
Primary Endpoint
Rate of CRT responder patients

Study Overview

Brief Summary

Observational, retrospective and perspective study with acute and chronic endpoints

Detailed Description

Study to assess the benefit from Multipoint Pacing (MPP) in presence of RV-to-LV delay<80ms in terms of rate of CRT responder patients at 6 Months from CRT-D system implantation

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Indication to CRT-D system implantation according to current guidelines or CRT-D system already implanted in patient scheduled to CRT-D system implantation according to current guidelines

Exclusion Criteria

  • Right Bundle Branch Block
  • Severe Irreversible Renal Failure (eGFR<30)
  • Atrio-Ventricular Block above the 1st grade
  • Prosthetic Valves
  • Atrial Fibrillation at implantation

Outcomes

Primary Outcomes

Rate of CRT responder patients

Time Frame: 6 Months

A patient is considered "responder" if Left Ventricular End-Systolic Volume at 6 Months from CRT-D system implantation is reduced at least of 15% towards the baseline value

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Monaldi Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Antonio D'Onofrio

MD

Monaldi Hospital

Study Sites (2)

Loading locations...

Similar Trials

Impact of MultiPoint Pacing Technology in... | Clinical Trial